轨迹 (Trk向药物):一种针对不同疾病的新疗法
George N Chaldakov1, Luigi Aloe2, Stanislav G Yanev3
1Departments of Anatomy and Cell Biology and Translational Stem Cell Biology, Research Institute, Medical University, 9002 Varna, Bulgaria.
Pharmaceuticals (Basel, Switzerland)
|July 27, 2024
概括
针对神经营蛋白受体 (Trk) 的治疗策略为逆转疾病提供了新的希望. "Trackins" (针对Trk的药物) 在心脏代谢和神经退行性疾病以及癌症方面表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 涉及蛋白激酶和酸酶的细胞信号通路调节细胞生长和功能.
- 神经营养素,如来自大脑的神经营养因子 (BDNF) 和神经生长因子 (NGF),在神经元的生存,生长和功能中起着至关重要的作用.
- 神经热素信号的失调与各种疾病有关,包括心脏代谢障碍和神经退行性疾病.
研究的目的:
- 更新和扩大用于治疗干预的"轨道" (Trk向药物) 的概念.
- 探索对抗神经素缺乏症相关心脏代谢和神经退行性疾病治疗的激动性跟踪素的潜力.
- 调查对抗性轨迹素,特别是TrkA(NGF) 抑制剂,用于治疗癌症,疼痛和心律失常的实用性.
主要方法:
- 对神经和它们的Trk受体发表的研究进行了审查和综合.
- 分析特定的神经热素-Trk相互作用在疾病发病过程中的作用.
- 作为治疗剂的"轨道"的概念框架开发.
主要成果:
- 抗原特拉基因显示出治疗高血压,2型糖尿病,阿尔茨海默病和帕金森病等疾病的潜力.
- 对抗性素,特别是TrkA(NGF) 抑制剂,对前列腺癌,乳腺癌,疼痛控制和心律失调的右腹腔失调有前途.
- 通过轨迹蛋白,TrkA(NGF),TrkA(pro-NGF),TrkB(BDNF) 和TrkC(NT-3) 受体的药物可用性得到了现有数据的支持.
结论:
- 轨迹蛋白代表了一种针对Trk受体的新型药物,用于各种治疗应用.
- 进一步的翻译性研究是有必要的,以充分实现trackins在治疗心脏代谢,神经退行性和瘤疾病的临床潜力.
- 准神经变蛋白受体通路为开发有效疗法以逆转疾病表型提供了一个有希望的途径.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.这就是为什么BDNF是BDNF.国家自然资源基金 (NGF)美国国家安全委员会 NT-3在TRC受体中,TRC受体是什么?针对轨道的药物 (轨道)癌症 癌症 癌症 癌症 癌症心脏代谢疾病心脏代谢疾病疼痛 疼痛 疼痛 疼痛在proNGFF中使用.更多相关视频
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
7.9K
10:04Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
12.0K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
01:26Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:24Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K